Cat.#: BBM-3C-022
| Description | Mouse Collagen Type I and III, 5 mg from Ace Therapeutics is purified from rom tail tendons of the mouse. Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function. |
| Source | Mouse tail tendons |
| Size | 5 mg/ vial |
| Form | Lyophilized, salt-free |
| Purity | Murine collagen type I - 45%. Murine collagen type III - 45%. Murine collagen type IV - 10%. Murine collagen type V - below 1%. Non-collagen proteins - below 0.5%. |
| Sterility | Passed sterility test for bacteria and fungi. |
| Storage | Storage (2 years) at -20°C or lower. |
| Shipping | Dry ice |
| Aplications | Used for coating material for cell culture studies. May not be suitable for 3-D gel formation. |
| Cat.# | Name | Description | Price |
|---|---|---|---|
| BBM-3C-068 | Mouse Collagen IV |
Mouse Collagen IV from Ace Therapeutics is a stromal extracellular matrix protein purified from a murine engelbreth-holm-swarm (EHS) tumor. This product can promote cell adhesion in cell and tissue cultures as well as be used as a hydrogel or thin coating for tissue culture vessels.
|
inquiry |
| BBM-3C-035 | Human Collagen Type V, 0.1mg |
Human Collagen Type V, 0.1mg from Ace Therapeutics is purified from human placenta.
Type V collagen, a fibrillar collagen, is critical for the fibrillation of types I and III collagen, contributing to optimal fibril formation and tissue quality.
|
inquiry |
| BBM-3C-061 | Collagens Type I-C |
Collagens Type I-P is pepsin-solubilized Type-I collagen derived from pig skin. This product is suitable for coating.
|
inquiry |
| BBM-3C-036 | Rat Tail Tendon Collagen Type I |
Rat Tail Tendon Collagen Type I from Ace Therapeutics is purified from rat tail by the Birkedal-Hansen method. This product can form a three-dimensional glue with a certain strength when the concentration is above 1mg/mL and the pH is around 7.
Note: This product can quickly gel at RT when the pH is neutral. Keep the temperature as low as possible during the operation.
|
inquiry |
| BBM-3C-062 | Collagens Type Ⅳ |
Collagens Type IV is derived from bovine tissue treated with pepsin. This product does not gel and needs to be mixed with collagen type I-A.
|
inquiry |
| BBM-3C-049 | Human Collagen Type I |
Human Collagen Type I from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and this product can be used as a thin layer on tissue culture surfaces to enhance cell adhesion and valorization.
|
inquiry |
| BBM-3C-050 | Bovine Collagen Type I |
Bovine Collagen Type I from Ace Therapeutics is a purified collagen derived from bovine tissue. The native collagen sequence contained in the preparation is missing or shortened since this product has been treated with pepsin.
|
inquiry |
| BBM-3C-040 | Collagen Type IV from Human Cell Culture |
Collagen Type IV from Human Cell Culture from Ace Therapeutics is derived from human fibroblasts and epithelial cells in a co-culture system, which creates an in vitro ECM (extracellular matrix) and serves as an excellent biological scaffold for three-dimensional cell culture.
|
inquiry |
| BBM-3C-041 | Human Collagen Type IV |
Human Collagen Type IV from Human Cell Culture from Ace Therapeutics is derived from human placenta.
|
inquiry |
| BBM-3C-051 | Human Collagen Type III |
Collagen Type III is found in a variety of conjunctival tissues, including human skin, and the cornea. Human Collagen Type III from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used as a coating on tissue culture surfaces to promote cell adhesion and regulate cell behavior.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.